Uneven Nutrition and Life Style as IBD Triggers in Adolescents and Adults
Not applicable · Testing Nordiet · 1 site · Region Skane
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
This study is testing Nordiet (a dietary supplement) as a possible treatment. Condition(s) listed: Mb Crohn and Ulcerative Colitis (UC).
It is open-label: participants know what they are receiving.
This study does not use drug-development phases (it may test a device, diet, procedure, app, or care approach).
Who can join
- Ages 18 to 35
- Any sex
Some of the main requirements, copied from the record:
- IBD, i.e., Mb Crohn or ulcerrative colitis
- Moderatively active disease (calprotectin 200-600)
There are also 8 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 160 participants are expected to take part.
- Start date: 2026-04-28.
- Main results expected around 2029-06 (estimate from the record).
- 1 study site listed (1 marked recruiting) in Sweden.
Main thing being measured
- Microbial composition (Four weeks)
In the researchers’ words
The aims of the study are 1. to determine the effect on dysbiosis, permeability and inflammatory activity after administration of a Mediterranean like diet (a Nordic equivalent, "Nordiet"), 2. to investigate life style related factors, such as exercise, psychosexual health and quality of life and their relation to the disease activity.
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Recruiting |
|---|---|
| Phase | Not applicable |
| Study type | Interventional |
| Conditions | Mb Crohn; Ulcerative Colitis (UC) |
| Lead sponsor | Region Skane |
| Collaborators | Malmö University; Lund University; Linkoeping University |
| Enrollment | 160 (estimated) |
| Start date | 2026-04-28 |
| Primary completion (est.) | 2029-06 |
| First posted | 2026-02-05 |
| Last updated | 2026-04-29 |
| Official title | Uneven Nutrition and Life Style as IBD Triggers in Adolescents and Adults |
| ClinicalTrials.gov ID | NCT07389161 |
Interventions
- Nordiet (Dietary Supplement)
Intervention with a Mediterranean like diet, the so called "Nordiet" during four weeks.
Full eligibility criteria (from the record)
Inclusion Criteria: * IBD, i.e., Mb Crohn or ulcerrative colitis * Moderatively active disease (calprotectin 200-600) Exclusion Criteria: * Proctitis alone * Inactive disease * Severe flare up requiring in-patient care * Planned change of treatment * Antibiotic treatment during the last month * Pregnancy * Inability to understand Swedish * Multimorbidity
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| Skåne University Hospital | Malmö | Sweden | Recruiting |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.